Clinical Trial Update: CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)

View source ↗

Summary

Clinical trial update on CARIATIDE evaluating adherence to aromatase inhibitors in routine breast cancer care through an educational program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Exemestane (Exemestane)
• Letrozole (letrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED